Hyperoxia as a driver of gut dysbiosis
Frontiers in Microbiology · 13.11.2025 · 16
DOI: 10.3389/fmicb.2025.1675652 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 13.11.2025. Verfasst von Hang Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Guizhou Province, Zunyi Science and Technology Planning Project.
Abstract (Originalsprache)
The mammalian colon lumen exists in a highly anaerobic environment (oxygen partial pressure (PO 2 ) < 1 mmHg), which promotes the growth of beneficial obligate anaerobes (OA) while limiting the expansion of pathogenic facultative anaerobes (FA). Gut dysbiosis is associated with a wide range of human diseases, and is often characterized by an overgrowth of FA, particularly those in the Enterobacteriaceae family. Oxygen (O 2 ) plays a crucial role in bacterial physiology and ecology, and increased O 2 availability is a key driver of gut dysbiosis. O 2 therapy is commonly used for hypoxic patients, either through inhalation or extracorporeal membrane oxygenation (ECMO), both of which can expose the gut to excess O 2 , known as hyperoxia. Hyperoxia leads to the overproduction of reactive O 2 species, resulting in organ injury and worsening clinical outcomes. Viewing gut dysbiosis from an ecological perspective highlights the disruption of host mechanisms that regulate the gut microbiota, particularly in the context of antibiotic use and a western (low fiber) diet, where physiological hypoxia in the colonic epithelium is compromised. This review extends that perspective to O 2 therapy in acute care, discussing the rationale and experimental evidence linking hyperoxia to gut dysbiosis, with a focus on venoarterial (VA)-ECMO support as a potential contributor. Understanding these mechanisms could help clinicians optimize O 2 management during therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Department of Pharmacy, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Department of Respiratory and Critical Care Medicine, Kweichow Moutai Hospital, Zunyi, China.
- Department of Nephrology, Kweichow Moutai Hospital, Zunyi, China.
- Guizhou Provincial Key Laboratory of Medicinal Biotechnology in Colleges and Universities, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Guizhou Province
- Zunyi Science and Technology Planning Project
- Kweichow Moutai Hospital
- Educational Department of Guizhou Province
Zitieren
APA
Wu, H., Zeng, W., Dai, N., Gu, J., He, Y., Qin, H., Lin, L., Fu, X., Fu, B., & Xing, Z. (2025). Hyperoxia as a driver of gut dysbiosis. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1675652
Vancouver
Wu H, Zeng W, Dai N, Gu J, He Y, Qin H, et al. Hyperoxia as a driver of gut dysbiosis. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1675652
BibTeX
@article{Wu2025,
author = {Wu, Hang and Zeng, Wenxia and Dai, Ninan and Gu, Juan and He, Ying and Qin, Han and Lin, Long and Fu, Xiaoyun and Fu, Bao and Xing, Zhouxiong},
title = {Hyperoxia as a driver of gut dysbiosis},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1675652}
}
EUVIMED